STAT3 mutations are highly specific for large granular lymphocytic leukemia.
about
Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia.The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells.Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes.Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.STAT3 in Cancer-Friend or Foe?STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug ResistanceAre T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder really two distinct diseases?Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approachCyclophosphamide as a first-line therapy in LGL leukemia.Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8+ TCR-Vβ+ expansions.Mutations in the signal transducer and activator of transcription family of genes in cancer.Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia
P2860
Q30278603-CAAE7D02-44F3-4DE5-92BA-8EC7A2DD7F9CQ30303161-49509C50-A6D9-4822-B23B-937D182BDA37Q34445129-14944F5D-2648-4380-B85F-48316CC9D76CQ34649095-B42E2976-735E-44C1-AF58-AD10DC7B3072Q37390232-455040F2-704E-4B9A-988D-AD6D8D3200BEQ38186800-62165FDC-4FAD-4CD6-9332-6070082774FCQ38226313-F067D05F-CCAF-445D-BAEB-B5FFCBB94182Q38536624-85A93857-C72D-49F0-B45C-00260201F7CEQ38978884-5D018D31-CD2F-4967-8FC8-31CFB0A98B0BQ41162138-464BE0D8-8358-4B91-B56D-71162E56A6CBQ42021237-EFBCAA58-FECE-41DA-8B2F-1B10C752D312Q42563534-D0141FAA-00D7-436B-B984-FCF65C20D94BQ47113855-C027E257-D733-4209-9DAF-16688C38EFEBQ49276933-E178CD50-80E9-4F8B-B114-BAF30002505BQ50124900-42B6D140-0E07-4ACA-90DF-4C450463CA7FQ58793391-383C56C9-A8DA-4ABE-BD6E-317CD3019471
P2860
STAT3 mutations are highly specific for large granular lymphocytic leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
STAT3 mutations are highly specific for large granular lymphocytic leukemia.
@en
STAT3 mutations are highly specific for large granular lymphocytic leukemia.
@nl
type
label
STAT3 mutations are highly specific for large granular lymphocytic leukemia.
@en
STAT3 mutations are highly specific for large granular lymphocytic leukemia.
@nl
prefLabel
STAT3 mutations are highly specific for large granular lymphocytic leukemia.
@en
STAT3 mutations are highly specific for large granular lymphocytic leukemia.
@nl
P2093
P2860
P356
P1433
P1476
STAT3 mutations are highly specific for large granular lymphocytic leukemia.
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2012.350
P577
2012-12-04T00:00:00Z